Literature DB >> 17609235

Hypersensitivity reaction to amiodarone in a patient with a previous reaction to an iodinated radiocontrast agent.

Leanne Stafford1.   

Abstract

OBJECTIVE: To describe a case of a hypersensitivity reaction to oral amiodarone in a patient with a previous reaction to an iodinated radiocontrast agent. CASE
SUMMARY: A 55-year-old man experienced facial urticaria after intraarterial injection of iohexol, an iodinated radiocontrast agent, during coronary angiography, which was successfully treated with intravenous hydrocortisone and promethazine. The procedure revealed significant triple vessel disease, and the patient subsequently underwent coronary artery bypass grafting in October 2006. Postoperatively, the patient experienced 2 episodes of fast atrial fibrillation, the first of which was treated successfully with intravenous amiodarone. The second episode resulted in the commencement of therapy with oral amiodarone 400 mg 3 times daily. Within one hour after the first dose, the patient experienced lip swelling and tingling, which was again treated with intravenous promethazine. Amiodarone was stopped; the patient remained in sinus rhythm and was discharged without further incident. DISCUSSION: Amiodarone is a class III antiarrhythmic agent frequently used in the management of atrial fibrillation after cardiac surgery. The approved product information lists known hypersensitivity to iodine as a contraindication to its administration, but no other cases of amiodarone hypersensitivity in a patient with a previous reaction to an iodinated radiocontrast agent have been published. Conversely, it has been suggested that the drug may be safely used in such patients. The Naranjo probability scale supported a probable adverse reaction of hypersensitivity associated with amiodarone therapy in this patient.
CONCLUSIONS: Prescribers should exercise caution in the administration of amiodarone to patients with a true, documented history of hypersensitivity to an iodinated compound.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609235     DOI: 10.1345/aph.1K027

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  3 in total

Review 1.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

2.  Evaluating pharmacists' knowledge, attitude, and practices toward amiodarone cross-reactivity with iodine: a cross-sectional pilot study.

Authors:  Nura Abdullah Alshehab; Munirah Abdullah Alhumaid; Mohammed Abdulrazaq Alabdulwahed; Abdulaziz Saleh Almulhim
Journal:  PeerJ       Date:  2022-07-08       Impact factor: 3.061

3.  Anaphylactic Shock as a Rare Side Effect of Intravenous Amiodarone.

Authors:  Aisha Batool; Khadija Batool; Hafsa Habib; Shahzad Chaudhry
Journal:  Cureus       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.